Neoadjuvant immunotherapy is expanding treatment options in CSCC by shrinking complex tumors, improving surgical outcomes, ...

Squamous cell carcinoma treatment varies by stage, involving surgery, radiation, and systemic therapies based on cancer progression and patient health. Stage 1 focuses on tumor removal, Stage 2 ...

A team led by scientists from the Universities of Manchester and Liverpool have revealed why a group of cancers common in ...

The incidence of early-onset oral cavity squamous cell carcinoma on the tongue, the most common subsite, increased over time.

C5aR1 expression correlates with increased metastasis risk and poor survival in cSCC patients. The tumor microenvironment, especially fibroblasts, influences C5aR1 expression and cSCC progression.

Libtayo's FDA approval offers an effective adjuvant option for high-risk cutaneous squamous cell carcinoma, reducing recurrence risk by 68% in the C-POST trial. Administered post-surgery and radiation ...

Comparing metagenomic profiles of the skin microbiome in immunosuppressed patients and those at high and low risk for cutaneous squamous cell carcinoma (SCC) revealed distinct expansions in fungal and ...

In a retrospective study, Hispanic patients developed a second cutaneous squamous cell carcinoma (cSCC) less frequently and later than non-Hispanic patients. Researchers evaluated 65 Hispanic patients ...

A piece of chewing gum may sound out of place in a cancer lab. Yet in this case, it became the delivery system for two ...

There are three common types of skin cancer in the United States: basal cell carcinoma, squamous cell carcinoma and melanoma. Merkel cell carcinoma is a rare type of skin cancer. Fred Hutch Cancer ...